Fundraising Fox
/Companies
Sign in

QurieGen

6 known investors

Find your way into QurieGen

Sign up to see every warm intro you have to QurieGen

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the QurieGen team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

QurieGen develops QuRIE-seq, a single-cell multi-omics platform that captures time-resolved single-cell data and trains lab-in-the-loop AI Virtual Cell models to predict cellular behavior and drug response. Spun out of the Huck Lab at Radboud University, the company serves pharmaceutical drug discovery and R&D.

AI & Machine LearningBiotechDeep TechMedical Devices

Investors · 6

Draper Associateslisted by Draper AssociatesSan Mateo · $500K – $5M

How we know: blog.tensor.ventures · Not right? Tell us

Lighthouse VenturesreportedPrague · $220K – $1.1M

How we know: funding news · blog.tensor.ventures · open dataset · 5k.vc investor directory · Not right? Tell us

Tensor VenturesreportedSenningerberg

How we know: funding news · blog.tensor.ventures · Not right? Tell us

Also in the syndicate · 2

22 Hor InvestMoondust Ventures

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 2

PixelgenPixelgen develops DNA-based visualization technology for cell-surface proteomics, enabling nanoscale spatial analysis of immune cell proteins for precision medicine and translational research. The company's Proximity Network Assay platform supports applications in immunology, hematology, and cell therapy diagnostics and therapeutics.
VizgenVizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples. The company serves research and diagnostic laboratories in the life sciences and precision oncology fields.

Companies working in the same space as QurieGen.

Frequently asked questions

What does QurieGen do?
QurieGen develops QuRIE-seq, a single-cell multi-omics platform that captures time-resolved single-cell data and trains lab-in-the-loop AI Virtual Cell models to predict cellular behavior and drug response. Spun out of the Huck Lab at Radboud University, the company serves pharmaceutical drug discovery and R&D.
Who are QurieGen's investors?
QurieGen's investors include BSV Ventures, Draper Associates, Lighthouse Ventures, Tensor Ventures.